Search results for "Highlights"
Spotlight on esophageal adenocarcinoma
High-dose proton-pump inhibitors and aspirin appeared effective for chemoprevention in patients with Barrett's esophagus in one study, while another study found a positive association between human papillomavirus status and survival in patients with Barrett's high-grade dysplasia and esophageal adenocarcinoma.
https://gastroenterology.acponline.org/archives/2018/08/24/5.htm
24 Aug 2018
PPI use associated with more severe illness from COVID-19
A Korean cohort study did not find any association between use of proton-pump inhibitors (PPIs) and risk of infection with SARS-CoV-2, but current use was associated with higher risk of a composite endpoint that included ICU admission, mechanical ventilation, or death from COVID-19.
https://gastroenterology.acponline.org/archives/2020/08/28/1.htm
28 Aug 2020
More concentrated care linked to adverse outcomes in patients with cirrhosis
A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
https://gastroenterology.acponline.org/archives/2020/01/24/2.htm
24 Jan 2020
Liver function tests at admission could help predict mortality from COVID-19
Elevations in aspartate aminotransferase and direct bilirubin levels were significantly more common among patients in China who died of COVID-19 than those who survived to hospital discharge, a retrospective study found.
https://gastroenterology.acponline.org/archives/2021/01/22/1.htm
22 Jan 2021
Specialty groups offer updated guidelines on care surrounding bariatric surgery
The update from endocrinology, obesity, surgery, anesthesiology, and nutrition experts covers perioperative nutritional, metabolic, and nonsurgical support of patients undergoing bariatric procedures.
https://gastroenterology.acponline.org/archives/2019/11/22/3.htm
22 Nov 2019
Semaglutide showed some benefit in patients with NASH, liver fibrosis
Significantly more patients taking the glucagon-like peptide-1 receptor agonist had resolution of their nonalcoholic steatohepatitis (NASH) than those taking placebo, but rates of liver fibrosis improvement were similar between groups, an industry-funded trial found.
https://gastroenterology.acponline.org/archives/2020/11/20/1.htm
20 Nov 2020
Safe to stop 5-ASA therapy for Crohn's disease when anti-TNF agent is started, study finds
A retrospective trial showed no increase in new corticosteroid therapy or disease-related hospitalization or surgery among patients who discontinued 5-aminosalycilate (5-ASA) therapy when initiating an anti-tumor necrosis factor (anti-TNF) agent.
https://gastroenterology.acponline.org/archives/2019/08/23/3.htm
23 Aug 2019
Anti-TNF therapy did not reduce IBD hospitalizations or intestinal resections in Ontario
Infliximab may have been used inappropriately in Crohn's disease and underused in ulcerative colitis, according to the authors of an analysis of hospitalizations, intestinal resections, and drug costs related to inflammatory bowel disease (IBD).
https://gastroenterology.acponline.org/archives/2019/06/28/3.htm
28 Jun 2019
Spotlight on ulcerative colitis
In the past month, the American Gastroenterological Association published new recommendations, a meta-analysis compared first- and second-line treatments, and a study found a recent decrease in colorectal cancer incidence in patients with ulcerative colitis.
https://gastroenterology.acponline.org/archives/2020/01/24/5.htm
24 Jan 2020
Fatty liver disease associated with increased risk of COVID-19 infection, hospitalization
However, patients who were obese but did not have fatty liver disease were not at increased risk of hospitalization for COVID-19, according to a study of healthy people in a U.K. database who underwent MRI assessment of liver fat markers.
https://gastroenterology.acponline.org/archives/2021/04/23/1.htm
23 Apr 2021